Thirona’s CEO and Founder, Eva van Rikxoort, joins this episode to share how their FDA-approved device is now integrating into the clinical workflow to both enhance physician performance and patient outcomes. LungQ is built on more than 10 years of clinical trials and 200+ publications to utilize AI allowing automatic segmentation of pulmonary segments and subsegments found in the internal anatomy of the lung.

This clearer understanding of lung anatomy helps enable broader adoption of minimally invasive treatments for lung diseases such as COPD and lung cancer, helping save more healthy lung tissue and lung function capacity. Acting as a map for lung anatomy, LungQ helps guide bronchoscopic navigation, leveraging AI to significantly enhance the precision, accuracy, and efficiency of bronchoscopic and surgical lung interventions.

With such emerging AI applications comes a wonderful story of a mission-driven team that is connecting across continents to bring new levels of precision and accuracy to patients. As a scientist turned entrepreneur, Eva demonstrates all the characteristics of a great leader who is building a collaborative model for success. If you’re looking to learn how AI-powered software should be leveraged, then tune in to be informed and inspired.